Tech Company Financing Transactions
Peptimmune Funding Round
Peptimmune, operating out of Cambridge, secured $41.2 million from MPM Capital, New Enterprise Associates and Covera Ventures.
Transaction Overview
MPM Capital (Lead Investor) (Luke Evnin)
New Enterprise Associates (Lead Investor) (James Barrett)
Prism VentureWorks (John Brooks)
Vanguard Ventures (Hugh Rienhoff)
Company Information
Cambridge, MA 02139
USA
Management Team
Browse more venture capital transactions:
Prev: 3/12/2003: Solstice Software venture capital transaction
Next: 3/17/2003: LiveCapital venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs